219 related articles for article (PubMed ID: 37936608)
1. The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer.
Herrera-Quiterio GA; Encarnación-Guevara S
Front Oncol; 2023; 13():1244740. PubMed ID: 37936608
[TBL] [Abstract][Full Text] [Related]
2. TMEM Proteins in Cancer: A Review.
Schmit K; Michiels C
Front Pharmacol; 2018; 9():1345. PubMed ID: 30574087
[TBL] [Abstract][Full Text] [Related]
3. The expression characteristics of transmembrane protein genes in pancreatic ductal adenocarcinoma through comprehensive analysis of bulk and single-cell RNA sequence.
Ye C; Ren S; Sadula A; Guo X; Yuan M; Meng M; Li G; Zhang X; Yuan C
Front Oncol; 2023; 13():1047377. PubMed ID: 37265785
[TBL] [Abstract][Full Text] [Related]
4. Signaling events at TMEM doorways provide potential targets for inhibiting breast cancer dissemination.
Surve CR; Duran CL; Ye X; Chen X; Lin Y; Harney AS; Wang Y; Sharma VP; Stanley ER; Cox D; McAuliffe JC; Entenberg D; Oktay MH; Condeelis JS
bioRxiv; 2024 Mar; ():. PubMed ID: 38260319
[TBL] [Abstract][Full Text] [Related]
5. Transmembrane (TMEM) protein family members: Poorly characterized even if essential for the metastatic process.
Marx S; Dal Maso T; Chen JW; Bury M; Wouters J; Michiels C; Le Calvé B
Semin Cancer Biol; 2020 Feb; 60():96-106. PubMed ID: 31454669
[TBL] [Abstract][Full Text] [Related]
6. TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progression.
Zhang TM; Liao L; Yang SY; Huang MY; Zhang YL; Deng L; Hu SY; Yang F; Zhang FL; Shao ZM; Li DQ
Autophagy; 2023 Mar; 19(3):805-821. PubMed ID: 35920704
[TBL] [Abstract][Full Text] [Related]
7. TMEM45A Affects Proliferation, Apoptosis, Epithelial-Mesenchymal Transition, Migration, Invasion and Cisplatin Resistance of HPV-Positive Cervical Cancer Cell Lines.
Liu Y; Liu L; Mou ZX
Biochem Genet; 2022 Feb; 60(1):173-190. PubMed ID: 34143331
[TBL] [Abstract][Full Text] [Related]
8. The matrix environmental and cell mechanical properties regulate cell migration and contribute to the invasive phenotype of cancer cells.
Mierke CT
Rep Prog Phys; 2019 Jun; 82(6):064602. PubMed ID: 30947151
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of TMEM45A overcomes multidrug resistance and epithelial-mesenchymal transition in human colorectal cancer cells through inhibition of TGF-β signalling pathway.
Zhu M; Jiang B; Yan D; Wang X; Ge H; Sun Y
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):503-516. PubMed ID: 31788833
[TBL] [Abstract][Full Text] [Related]
10. Transmembrane protein 88 inhibits transforming growth factor-β1-induced-extracellular matrix accumulation and epithelial-mesenchymal transition program in human pleural mesothelial cells through modulating TGF-β1/Smad pathway.
Sun Z; Ning Q; Li H; Hu T; Tang L; Wen Q; Shen L
J Recept Signal Transduct Res; 2022 Feb; 42(1):60-66. PubMed ID: 33167758
[TBL] [Abstract][Full Text] [Related]
11. Structural, topological, and functional characterization of transmembrane proteins TMEM213, 207, 116, 72 and 30B provides a potential link to ccRCC etiology.
Wesoly J; Pstrąg N; Derylo K; Michalec-Wawiórka B; Derebecka N; Nowicka H; Kajdasz A; Kluzek K; Srebniak M; Tchórzewski M; Kwias Z; Bluyssen H
Am J Cancer Res; 2023; 13(5):1863-1883. PubMed ID: 37293153
[TBL] [Abstract][Full Text] [Related]
12. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
13. Assessment of MRI to estimate metastatic dissemination risk and prometastatic effects of chemotherapy.
Karagiannis GS; Bianchi A; Sanchez LR; Ambadipudi K; Cui MH; Anampa JM; Asiry S; Wang Y; Harney AS; Pastoriza JM; Lin Y; Chen X; Jones JG; Entenberg D; Haddad D; Hodges LJ; Duong TQ; Sparano JA; Oktay MH; Branch CA; Condeelis JS
NPJ Breast Cancer; 2022 Sep; 8(1):101. PubMed ID: 36056005
[TBL] [Abstract][Full Text] [Related]
14. NDRG2 suppresses proliferation, migration, invasion and epithelial-mesenchymal transition of esophageal cancer cells through regulating the AKT/XIAP signaling pathway.
Yang CL; Zheng XL; Ye K; Ge H; Sun YN; Lu YF; Fan QX
Int J Biochem Cell Biol; 2018 Jun; 99():43-51. PubMed ID: 29530788
[TBL] [Abstract][Full Text] [Related]
15. Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors.
Wrzesiński T; Szelag M; Cieślikowski WA; Ida A; Giles R; Zodro E; Szumska J; Poźniak J; Kwias Z; Bluyssen HA; Wesoly J
BMC Cancer; 2015 Jul; 15():518. PubMed ID: 26169495
[TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination.
Robinson BD; Sica GL; Liu YF; Rohan TE; Gertler FB; Condeelis JS; Jones JG
Clin Cancer Res; 2009 Apr; 15(7):2433-41. PubMed ID: 19318480
[TBL] [Abstract][Full Text] [Related]
17. microRNA-33a prevents epithelial-mesenchymal transition, invasion, and metastasis of gastric cancer cells through the Snail/Slug pathway.
Chen DD; Cheng JT; Chandoo A; Sun XW; Zhang L; Lu MD; Sun WJ; Huang YP
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G147-G160. PubMed ID: 30943047
[TBL] [Abstract][Full Text] [Related]
18. TMEM229A suppresses non‑small cell lung cancer progression via inactivating the ERK pathway.
Zhang X; He Y; Jiang Y; Bao Y; Chen Q; Xie D; Yu H; Wang X
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34184076
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal dysfunction and early glial activation are involved in the pathogenesis of spinocerebellar ataxia type 21 caused by mutant transmembrane protein 240.
Seki T; Sato M; Kibe Y; Ohta T; Oshima M; Konno A; Hirai H; Kurauchi Y; Hisatsune A; Katsuki H
Neurobiol Dis; 2018 Dec; 120():34-50. PubMed ID: 30184469
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-590-5p functions as a tumor suppressor in breast cancer conferring inhibitory effects on cell migration, invasion, and epithelial-mesenchymal transition by downregulating the Wnt-β-catenin signaling pathway.
Gao J; Yu SR; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
J Cell Physiol; 2019 Feb; 234(2):1827-1841. PubMed ID: 30191949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
